$355.88
+2.32 (+0.656%)
At Close: Jun 22, 2026
VIS: Industrials Are As Expensive As Information Technology
12:26pm, Monday, 22'nd Jun 2026
Vanguard Industrials ETF closely tracks the MSCI US IMI/Industrials 25/50 Index, offering broad industrial sector exposure. VIS employs a replication strategy, mirroring index holdings and weightings,
Should You Invest in the Vanguard Industrials Index Fund ETF Shares (VIS)?
07:20am, Wednesday, 17'th Jun 2026
If you're interested in broad exposure to the Industrials - Broad segment of the equity market, look no further than the Vanguard Industrials Index Fund ETF Shares (VIS), a passively managed exchange
TSMC reduces VIS ownership after announcing massive share sale
04:56am, Friday, 15'th May 2026
Taiwan Semiconductor Manufacturing Company said on Friday that it is planning to sell up to 152 million shares in Vanguard International Semiconductor through a block trade to institutional investors.
Eagle Wealth Advisors LLC Acquires Shares of 2,882 Vanguard Industrials ETF $VIS
05:10am, Monday, 27'th Apr 2026
Eagle Wealth Advisors LLC acquired a new stake in shares of Vanguard Industrials ETF (NYSEARCA:VIS) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange
Visionstate Adds Ontario Health Region, Expands Recurring Revenue and U.S. Footprint
09:00am, Wednesday, 15'th Apr 2026
Edmonton, Alberta--(Newsfile Corp. - April 15, 2026) - Visionstate Corp. (TSXV: VIS) today announced the addition of a new Ontario-based health region to its compliance software platform, representing
Should You Invest in the Vanguard Industrials Index Fund ETF Shares (VIS)?
07:20am, Wednesday, 15'th Apr 2026
Launched on September 23, 2004, the Vanguard Industrials Index Fund ETF Shares (VIS) is a passively managed exchange traded fund designed to provide a broad exposure to the Industrials - Broad segment
Calder Financial LLC Purchases New Stake in Vanguard Industrials ETF $VIS
04:40am, Tuesday, 14'th Apr 2026
Calder Financial LLC purchased a new stake in Vanguard Industrials ETF (NYSEARCA:VIS) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Excha
Prediction: This Is the 1 Sector That Will Beat the S&P 500 in 2026
06:00am, Friday, 10'th Apr 2026
Sometimes, the least likely group ends up doing the best. But investors won't know for sure until the year is complete.
VIS: Industrials Soars Amid A U.S.-Iran Ceasefire, Expecting More Gains
10:57am, Wednesday, 08'th Apr 2026
Vanguard Industrials ETF receives a "Buy" rating, supported by robust technicals and sector resilience amid geopolitical developments. VIS trades at a premium 26x P/E and 2.3x PEG, but sector diversif
Capital Management Associates Inc Boosts Holdings in Vanguard Industrials ETF $VIS
04:43am, Monday, 06'th Apr 2026
Capital Management Associates Inc increased its stake in Vanguard Industrials ETF (NYSEARCA:VIS) by 76.8% during the undefined quarter, according to the company in its most recent Form 13F filing with
JPMorgan Chase & Co. Has $42.17 Million Stock Holdings in Vanguard Industrials ETF $VIS
04:51am, Sunday, 22'nd Mar 2026
JPMorgan Chase and Co. raised its stake in shares of Vanguard Industrials ETF (NYSEARCA:VIS) by 1.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange
Bank of America Corp DE Has $1.16 Billion Stock Position in Vanguard Industrials ETF $VIS
03:40am, Tuesday, 17'th Mar 2026
Bank of America Corp DE grew its holdings in Vanguard Industrials ETF (NYSEARCA:VIS) by 6.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm ow
NovaBridge Biosciences (NBP) Discusses Phase 2a Clinical Data and Development Plan for VIS-101 in Wet Age-Related Macular Degeneration Transcript
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
07:00am, Monday, 09'th Mar 2026
ROCKVILLE, Md., March 09, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform company committed to accelerating access to innovati
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026
09:05am, Tuesday, 03'rd Mar 2026
VIS-101, purpose-designed to be a best-in-class dual VEGF-A/ANG-2 inhibitor, has the potential to provide more effective and durable treatment than the current standard of care for patients with wet A
Sign In
Buy VIS